Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT06045247. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies
ClinicalTrials.gov study NCT06462248. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients
ClinicalTrials.gov study NCT05040906. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
ClinicalTrials.gov study NCT05773040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell Lymphoma
ClinicalTrials.gov study NCT03994913. IPD Sharing: NO. Countries: 1. Publications: 0.
Sequential Low-dose Decitabine With PD-1/CD28 CD19 CAR-T in Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT04850560. IPD Sharing: NO. Countries: 1. Publications: 0.
JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies
ClinicalTrials.gov study NCT07065279. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
ClinicalTrials.gov study NCT06581562. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting r/r B-cell Hematologic Malignancies
ClinicalTrials.gov study NCT05739227. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.
ClinicalTrials.gov study NCT00742495. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06824701. IPD Sharing: NO. Countries: 1. Publications: 0.
Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody)
ClinicalTrials.gov study NCT05453435. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL
ClinicalTrials.gov study NCT06321289. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT07011056. IPD Sharing: NO. Countries: 1. Publications: 0.
The Study of ICP-248 in Patients With Mature B-cell Malignancies
ClinicalTrials.gov study NCT05728658. IPD Sharing: NO. Countries: 1. Publications: 0.
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
ClinicalTrials.gov study NCT02109224. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02449265. IPD Sharing: Not stated. Countries: 1. Publications: 0.
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic M
ClinicalTrials.gov study NCT06191887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
ClinicalTrials.gov study NCT06566586. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects
ClinicalTrials.gov study NCT00498914. IPD Sharing: Not stated. Countries: 4. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.